None listed
Conditions
Interventions
A single intake of the peptide food
A single intake of the placebo food
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Subjects aged 20 years old or more and less than 65 years old. 2) Subjects whose fasting blood glucose levels are less than 126 mg/dL, and 2-h postprandial blood glucose levels are less than 200 mg/dL. 3) Subjects who have received a full explanation of the study, can understand its contents, and have given their written informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1) Subjects who are undergoing continuous medical treatment. 2) Subjects who regularly restrict carbohydrates. 3) Subjects who regularly take Foods for Specified Health Uses, Foods with Function Claims, health foods, etc., which may affect the study, and who cannot stop taking them during the study period. 4) Subjects who smoke 20 cigarettes or more per day. 5) Subjects with BMI of 30.0 kg/m2 or more. 6) Subjects who have difficulty in blood collection. 7) Subjects who excessively take alcohol. 8) Subjects who have a previous or current medical history of serious diseases in heart, liver, kidney, digestive organs, etc. 9) Subjects who are pregnant, planning to become pregnant, or lactating. 10) Subjects who have serious allergies to medicines and foods (especially eggs, wheat, and dairy products). 11) Subjects who are currently participating in another clinical trial of a drug or food, or participated in that trial within 4 weeks, or planning to participate in that trial after giving informed consent to participate in this trial. 12) Subjects who have donated over 200 mL of blood within 1 month and over 400 mL within 3 months before beginning this study. 13) Subjects who are judged as ineligible to participate in this study by the principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area under the curve of blood glucose levels (0-120 min) | — |
Secondary
| Measure | Time frame |
|---|---|
| Postprandial blood glucose levels (each time point), Cmax of blood glucose level, Tmax of blood glucose level, insulin levels (each time point), insulinogenic index | — |
Countries
Japan
Contacts
Public ContactMasanori NUMA
CPCC Company Limited Clinical Planning Department
Outcome results
None listed